| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 434.94B | 425.16B | 394.13B | 372.15B | 340.29B | 352.00B |
| Gross Profit | 65.31B | 60.96B | 43.31B | 42.02B | 46.86B | 48.16B |
| EBITDA | 38.14B | 42.33B | 21.85B | 21.95B | 28.12B | 27.50B |
| Net Income | 27.33B | 26.44B | 13.88B | 15.19B | 17.67B | 17.19B |
Balance Sheet | ||||||
| Total Assets | 350.97B | 371.97B | 334.14B | 318.01B | 295.33B | 339.61B |
| Cash, Cash Equivalents and Short-Term Investments | 61.86B | 57.29B | 50.21B | 75.60B | 66.08B | 129.32B |
| Total Debt | 32.97B | 27.90B | 23.63B | 24.11B | 24.71B | 25.27B |
| Total Liabilities | 179.85B | 199.79B | 179.68B | 176.69B | 153.65B | 192.94B |
| Stockholders Equity | 170.19B | 171.21B | 153.57B | 140.48B | 140.92B | 145.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.05B | -18.19B | 29.27B | -38.64B | 26.22B |
| Operating Cash Flow | 0.00 | 11.18B | -11.12B | 32.27B | -36.09B | 29.15B |
| Investing Cash Flow | 0.00 | 1.60B | -6.09B | -4.74B | -4.55B | -3.95B |
| Financing Cash Flow | 0.00 | -5.75B | -9.05B | -18.43B | -22.57B | -12.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥338.45B | 10.65 | 16.55% | 4.26% | 9.49% | 64.79% | |
76 Outperform | ¥387.36B | 12.31 | ― | 2.73% | 18.92% | 73.08% | |
76 Outperform | ¥521.46B | 10.71 | ― | 2.85% | ― | ― | |
75 Outperform | ¥227.59B | 12.65 | ― | 3.82% | -3.72% | 59.02% | |
73 Outperform | ¥154.91B | 12.09 | ― | 3.44% | 11.25% | 36.92% | |
68 Neutral | ¥431.75B | 21.43 | 10.95% | 1.91% | 16.67% | 5.82% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Hazama Ando Corporation reported a significant increase in its consolidated financial results for the six months ended September 30, 2025, with net sales rising by 7.6% and operating profit increasing by 24.2% compared to the previous year. The company also announced a forecasted annual dividend increase, reflecting strong financial health and a commitment to shareholder returns.